Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 12 studies | 37% ± 12% | |
| oligodendrocyte precursor cell | 12 studies | 42% ± 20% | |
| GABAergic neuron | 11 studies | 43% ± 20% | |
| astrocyte | 9 studies | 31% ± 17% | |
| glutamatergic neuron | 6 studies | 36% ± 6% | |
| interneuron | 5 studies | 51% ± 28% | |
| retinal pigment epithelial cell | 4 studies | 72% ± 17% | |
| GABAergic interneuron | 3 studies | 44% ± 12% | |
| epithelial cell | 3 studies | 44% ± 29% | |
| granule cell | 3 studies | 59% ± 14% | |
| neuron | 3 studies | 25% ± 10% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 13 studies | 33% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 98% | 789.79 | 2602 / 2642 | 64% | 2.40 | 450 / 705 |
| adrenal gland | 84% | 314.00 | 217 / 258 | 28% | 2.80 | 64 / 230 |
| blood vessel | 96% | 1275.67 | 1279 / 1335 | 0% | 0 | 0 / 0 |
| uterus | 83% | 249.10 | 141 / 170 | 5% | 0.22 | 23 / 459 |
| ovary | 79% | 219.08 | 142 / 180 | 1% | 0.05 | 6 / 430 |
| prostate | 54% | 108.66 | 133 / 245 | 9% | 0.16 | 43 / 502 |
| thymus | 38% | 51.66 | 250 / 653 | 5% | 0.18 | 31 / 605 |
| lung | 17% | 22.38 | 99 / 578 | 24% | 1.07 | 274 / 1155 |
| breast | 37% | 60.77 | 170 / 459 | 3% | 0.09 | 29 / 1118 |
| esophagus | 31% | 57.54 | 446 / 1445 | 3% | 0.09 | 6 / 183 |
| adipose | 34% | 55.08 | 405 / 1204 | 0% | 0 | 0 / 0 |
| stomach | 27% | 48.83 | 96 / 359 | 2% | 0.07 | 5 / 286 |
| intestine | 20% | 26.74 | 192 / 966 | 1% | 0.02 | 4 / 527 |
| kidney | 17% | 30.94 | 15 / 89 | 3% | 0.21 | 30 / 901 |
| tonsil | 0% | 0 | 0 / 0 | 20% | 0.43 | 9 / 45 |
| skin | 14% | 21.53 | 247 / 1809 | 4% | 0.30 | 21 / 472 |
| bladder | 10% | 10.90 | 2 / 21 | 4% | 0.20 | 18 / 504 |
| pancreas | 5% | 6.04 | 17 / 328 | 3% | 0.10 | 6 / 178 |
| heart | 5% | 5.62 | 41 / 861 | 0% | 0 | 0 / 0 |
| liver | 0% | 0.46 | 1 / 226 | 4% | 0.34 | 16 / 406 |
| spleen | 4% | 3.65 | 10 / 241 | 0% | 0 | 0 / 0 |
| muscle | 3% | 2.91 | 21 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.01 | 1 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0016020 | Cellular component | membrane |
| GO_0003824 | Molecular function | catalytic activity |
| Gene name | PLD5 |
| Protein name | Phospholipase D family member 5 Alternative protein PLD5 Inactive phospholipase D5 (Inactive PLD 5) (Inactive choline phosphatase 5) (Inactive phosphatidylcholine-hydrolyzing phospholipase D5) (PLDc) |
| Synonyms | |
| Description | |
| Accessions | ENST00000442594.6 [Q8N7P1-1] F5GXZ8 F8W7H1 F5H329 ENST00000459864.1 ENST00000467561.5 ENST00000314833.10 ENST00000536534.7 [Q8N7P1-1] Q8N7P1 J3KP61 ENST00000427495.5 [Q8N7P1-4] ENST00000366545.5 L8ECN2 |